How to make value-based care a reality? Impactful interventions to maximise healthspan. Viral hepatitis in Arkhangai: How Asia’s first micro-treatment program’s successes can be leveraged to treat a “silent killer”. The long-suffering challenge of vaccination.
No takes yet. Share an insight, caveat, or question.
A 2018 study studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: